Ablative Neurosurgical Techniques in the Treatment of Chronic Pain: Overview Timothy R

Total Page:16

File Type:pdf, Size:1020Kb

Ablative Neurosurgical Techniques in the Treatment of Chronic Pain: Overview Timothy R Chapter 50 Ablative Neurosurgical Techniques in the Treatment of Chronic Pain: Overview Timothy R. Steel and Kim J. Burchiel Conservative nonsurgical treatment, including rehabilita- clude neuroma pain, postrhizotomy pain, anesthesia do- tion therapy, is the mainstay of the treatment of most pa- lorosa, postherpetic neuralgia, sympathetically maintained tients with chronic pain, whereas neuroablative surgery is pain, complex regional pain syndrome (CRPS) I and II, pain indicated only in a minority. It is the selection of the patients following brachial plexus avulsion, spinal cord injury pain, who will benefit from ablative procedures that is critical. and the thalamic pain syndrome. The pain often is described Appropriate management of patients with chronic pain re- as burning or crushing. Shocklike exacerbations occur and quires a combined approach between pain specialists, reha- may be spontaneous in most deafferentation syndromes but bilitation teams, and, when necessary, neurosurgeons. Some also may be triggered by cutaneous stimulation, as seen with patients will not be candidates for surgery at any time, causalgia or sympathetically maintained pains. Neuropathic whereas others may become candidates after maximal con- pain is incapacitating and is usually refractory to all conserv- servative therapies have been exhausted. ative measures. Narcotic analgesics characteristically provide The exact time course for pain to be classified as chronic is only minimal relief. Anesthetic blockade proximal to the le- a matter more of convention than of science. Chronic pain sion may relieve deafferentation pain temporarily; however, has been described as that which persists beyond 1 month neuroablative procedures rarely provide lasting relief and after the normal course of an acute illness or after a reason- may cause an even more widespread deafferentation pain able time for an injury to have healed.1 The International As- state. In selected conditions, good results can be achieved by sociation for the Study of Pain stated that chronic pain is destructive procedures. The poor results of sensory pathway any pain that persists beyond the “normal time of healing.”2 ablation suggest that structures other than the spinothalamic Bonica suggested that 3 months is the best time of separa- tract and somatosensory relay nuclei of the thalamus are in- tion between acute and chronic pain.1 Because long-standing volved in the pathogenesis of deafferentation pain. pain experienced by patients with cancer or other chronic Although surgical ablative procedures can be effective in disease states becomes an illness in itself, the pain syndrome the management of chronic pain, they often are discarded as warrants treatment as a specific disorder on its own, no mat- a treatment option by many physicians because historically ter what the time constraints. these procedures are associated with a relatively high com- Chronic pain can be divided broadly into two kinds: no- plication rate. These complications include the development ciceptive pain and neuropathic (deafferentation) pain. Noci- of new deficits as a result of the ablative procedure and mor- ceptive pain results from stimuli that damage or severely bidity associated with operative procedures on high-risk pa- deform tissue and cause the conscious experience of pain. tients, such as those with end-stage cancer. In patients un- Trauma, inflammation, visceral distention, and neoplastic dergoing ablative surgery for benign pain syndromes, the infiltration all cause nociceptive pain. Narcotic analgesics long-term difficulties with pain recurrence and the develop- generally provide relief for such patients, although the po- ment of deafferentation pain also have contributed to thera- tential for these patients to experience tolerance and habitu- peutic nihilism in this area. ation is high. Anesthetic blockade, somatic nerve or root sec- Over the last two decades, the administration of in- tion, and spinothalamic tract section typically will abolish traspinal and intraventricular morphine has both improved nociceptive pain. and simplified the management of pain from many malig- The distinguishing features of neuropathic pain are shared nant processes.3 Direct delivery of small doses of opiates to by many different chronic pain syndromes associated with spinal and ventricular cerebrospinal fluid (CSF) provides ef- peripheral or central nervous system (CNS) injury. These in- fective analgesia in most patients without the major side 633 Surgical Management of Pain. Burchiel. Thieme Medical Publishers, Inc., New York © 2002 634 SURGICAL PROCEDURES effects of sedation, nausea, or constipation. Reported com- tients who survive for longer periods (>6 months), tolerance plications are rare, with more than 90% of patients reporting may develop, requiring greater doses, which may cloud con- significant benefits until death or last follow-up.3 Drug de- sciousness and impair judgment.3 It is these patients who will livery systems of varied complexity and expense are avail- benefit most from neuroablative procedures.7 able. Few patients are truly too ill to undergo the minimally If the neurosurgeon can offer selective neurodestructive invasive surgery necessary for implantation. procedures with minimal or at least acceptable morbidity, This chapter first reviews the general principles of pa- and ideally no mortality, neurodestructive procedures can tient selection for neuroablative procedures and then fo- reliably improve the quality of life for these patients. In cuses on the procedures currently available. We shall dis- some cases, this means the patient can be narcotic free cuss which procedures are appropriate to consider in the for substantial periods of his or her remaining life. In cases management of specific pain syndromes and where in the of narcotic-resistant pain, limited destructive neurosurgical treatment paradigm they should be applied. For most con- procedures often can provide pain relief for the duration of ditions, ablative techniques still are considered second-line the patient’s life.3 The estimated length of survival of these therapy. Only in a minority of situations would an ablative patients is important in determining a treatment strategy. surgical procedure be considered the primary treatment. Loeser believes that patients with less than 3 months’ life expectancy should not be considered surgical candidates because of their higher risk of significant morbidity and GENERAL CONSIDERATIONS mortality.7 In general, patients with expected survival of more than 6 months constitute better candidates for surgical To consider a patient for an ablative procedure, conservative procedures. They typically have lower surgical risk, and the nonsurgical therapy must have been attempted, maximized, analgesia that is produced can markedly reduce or even and fully evaluated as to reasons for failure. Of course, eliminate dependence on narcotic analgesics.11 Patients with medical treatment must be individualized, but it generally cancer pain are also more likely to have good results from consists of a combination of analgesics, antidepressants, and ablative procedures because their pain derives from direct often anticonvulsants. Nonsurgical peripherally applied stimulation of pain receptors and is transmitted in pain neuroaugmentative and counterirritation techniques such pathways (i.e., nociceptive), which are eliminated by neu- as transcutaneous electrical nerve stimulation (TENS) and rodestructive procedures.7 These patients are also often un- acupuncture also may be of benefit,4–6 and these should be likely to survive long enough for the benefits of the proce- tried if indicated. For the purposes of this chapter, we shall dures to disappear or for new pain syndromes to develop. assume that best medical therapies have been instituted for Rehabilitation techniques can be of value in the manage- all conditions unless otherwise stated. ment of patients with cancer pain. TENS and acupuncture Neurosurgical options in the relief of chronic pain in- techniques have been used successfully for a variety of clude (1) the electrical stimulation of the brain, spinal cord, painful conditions associated with malignancy.12,13 Physical or peripheral nerves, (2) the implantation of devices to de- therapy with the use of joint manipulation, stretching exer- liver drugs to the CSF, and (3) the destruction or incision of cises, muscle strengthening, and massage can help control neural tissue.7 Many of the ablative neurosurgical options pain caused by contractures and other soft-tissue and joint for chronic pain treatment are depicted in Figure 50–1. complications due to inactivity.14,15 The application of heat and cold can also be used to treat various cancer pain Malignant Pain problems.12,14 Relaxation therapy also can be of benefit in improving pain control as well as general patient well- Pain is experienced by one third of cancer patients who re- being.13,14 By whatever means, the primary goal of treatment ceive active treatment and by three quarters of those with in such patients is to render them pain free for the duration advanced disease.8 Because cancer pain usually is associ- of their remaining life. Their restricted life span often makes ated with structural pathology, definitions of the extent of long-term rehabilitation planning unfeasible. Expecting pa- the disease and the nature of the specific underlying cause tients with malignant disease to attempt rigorous and ex- of the pain are essential in the assessment
Recommended publications
  • I Think with Flying Colours, Express
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.50.9.1251 on 1 September 1987. Downloaded from Book reviews 1251 The eight biographies of disabled people differences. In the chapter on neirve blocking Intensive Care and Monitoring of the Neuro- with which the book begins demonstrate the procedures it is most refreshing tto see Charl- surgical. Patient (Progress in Neurological author's skill in empathising with individu- ton's cautious approach, criticalI analysis of Surgery Vol 12.) Edited by AM Landolt. als and outlining important aspects of aging methods and results, and warni ngs ("before (Pp 202; $74.00.) Basel: Karger, 1987. with disability. It is sad that there is no bet- embarking upon neurolytic block everyone ter book covering this topic. Why not? As should read the review of rnedico-legal It is unfortunate that this volume, dedicated the author says, saving lives attracts glam- aspects of complications that may follow to Hugo Krayenbuhl with such a good our and funds which are denied to services these procedures"). He states that intra- biography, has suffered the vicissitudes of for the saved. If this is true of spinal injury thecal use ofcold hypertonic saliine and bar- multiple authorship (so frankly acknowl- and poliomyelitis it is no less true of the botage of CSF "can now be regaLrded as his- edged in the editors' preface that it could be beneficiaries ofother miracles: for example a torical curiosities"; of epidural lblock "there taken as a lament upon this type of book); generation of people with spina bifida and is a distinct lack of published (data on the relatively little of the title is covered by the hydrocephalus now being launched into an injection of neurolytic solutions into the epi- contents, and the relationship of the eight adult world which has made no special dural space"; and neurolytic p;aravertebral contributions is seemingly haphazard.
    [Show full text]
  • Neurosurgery
    March 10, 2017 St Elizabeth Healthcare 9:02 am Privileges for: Neurosurgery Request ST. ELIZABETH - EDGEWOOD ST. ELIZABETH - FLORENCE ST. ELIZABETH - FT. THOMAS ST. ELIZABETH - GRANT CO. (Surgical & other invasive procedures requiring general anesthetic are not offered) MEC Approval: August 27, 2009; Rev. November 15, 2012, February 27, 2014 Board Approval: September 14, 2009; Rev. January 7, 2013, May 5, 2014 DEPARTMENT APPROVAL ________Approved ________Disapproved ___________________________________________ ________________ Department/Section Chair Signature Date MINIMUM REQUIREMENTS Degree required: MD or DO Successful completion of an ACGME or AOA accredited residency in neurosurgery. Note: For Practitoners (excluding AHPs) who apply for membership after March 2, 2009 be and remain (with a lapse of no longer than one year) board certified in their principal practice specialty, or become and remain (with a lapse of no longer than one year) board certified within six years of completion of their post-graduate medical training. Only those boards recognized by the American Board of Medical Specialties or the American Osteopathic Association are acceptable. This board certification requirement does not apply to applicants who on March 2, 2009 were members in good standing on the medical staff of the St. Luke Hospitals or St. Elizabeth Medical Center. PRIVILEGES REQUESTED Pursuant to Bylaws Section 6.1.4, practitioners may exercise the privileges requested and awarded below only at facilities where St. Elizabeth Healthcare offers those services. I. Core Privileges: Core privileges in neurosurgery include the care, treatment or services listed immediately below. I specifically acknowledge that board certification alone does not necessarily qualify me to perform all core privileges or assure competence in all clinical areas.
    [Show full text]
  • Study of Brain Mechanisms in Temporomandibular Disorder
    A Magnetoencephalographic (MEG) Study of Brain Mechanisms in Temporomandibular Disorder A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Aurelio Abdalla Alonso, DDS, MS IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DR. APOSTOLOS P. GEORGOPOULOS, ADVISER December 2009 © Aurelio Abdalla Alonso, December/2009 Acknowledgments I am thankful to my supervisor, Dr. Apostolos Georgopoulos, whose encouragement, guidance, support, patience and extraordinary mentorship throughout this journey enabled me to develop an understanding of this work. I would like to thank also the facial somesthesia team members: Dr. Art Leuthold for sharing his knowledge on MEG and his help in general; to Dr. Ioannis Koutlas for inviting me to participate in this amazing project, and help during patient collection and processing data; to Dr. Elissaios Karageorgiou for his technical and general help through this journey. My special thank to Dr. Scott Lewis for his time helping during MRI acquisition and consent forms; to Dr. May Tan for her help and patience during my MEG questions. To all Brain Sciences Center members that direct or indirect help me conquer this journey, especially my sincere appreciation to Mrs. Penny Becker and Mrs. Gail Hollstadt that were always there for me when I needed. Dr. Donald Simone, Dr. Alvin Beitz, Dr. Matt Chafee, and Dr. Darryl Hamamoto it was an honor for me to have you as part of my committee, my sincere gratitude. My many thanks to the Oral Biology Program crew: Dr. Mark Herzbeg for his inspirational conversation, and advices; to Michelle Lamere and Ann Hagen for their support during these years.
    [Show full text]
  • Coding Pain Management Services Notes/Comments/Questions
    Coding Pain Management Services Audio Seminar/Webinar April 3, 2008 Practical Tools for Seminar Learning © Copyright 2008 American Health Information Management Association. All rights reserved. Disclaimer The American Health Information Management Association makes no representation or guarantee with respect to the contents herein and specifically disclaims any implied guarantee of suitability for any specific purpose. AHIMA has no liability or responsibility to any person or entity with respect to any loss or damage caused by the use of this audio seminar, including but not limited to any loss of revenue, interruption of service, loss of business, or indirect damages resulting from the use of this program. AHIMA makes no guarantee that the use of this program will prevent differences of opinion or disputes with Medicare or other third party payers as to the amount that will be paid to providers of service. CPT® five digit codes, nomenclature, and other data are copyright 2007 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in CPT. The AMA assumes no liability for the data contained herein. As a provider of continuing education, the American Health Information Management Association (AHIMA) must assure balance, independence, objectivity and scientific rigor in all of its endeavors. AHIMA is solely responsible for control of program objectives and content and the selection of presenters. All speakers and planning committee members are expected to disclose to the audience: (1) any significant financial interest or other relationships with the manufacturer(s) or provider(s) of any commercial product(s) or services(s) discussed in an educational presentation; (2) any significant financial interest or other relationship with any companies providing commercial support for the activity; and (3) if the presentation will include discussion of investigational or unlabeled uses of a product.
    [Show full text]
  • Interventional Physiatry
    Interventional Physiatry Diagnosis Medical Branch Block & Radiofrequency Ablation Treatment Prepared by: Tufts PM&R Medical staff Overview and indications for procedure: Lumbar Facet joints (also known as the Zygapophysial joints or Z-joints) are paired structures on both side of your spine that allows movement between two vertebrae. When a facet joints are strained (car accident, fall, injuries) ,degenerative changes settles in these joints or there is a shift between two vertebrae (spondylolisthesis) , the joints could become the source of back pain. Pain may be localized to the lower back or radiating to the buttock, posterior hamstring, groin area or to side of the legs (colored figure credit: Nature Reviews Rheumatology 9 , 216-224 , April 2013) . Medial branch block: Pain information from the facet joints travels to the brain via small nerve endings called medial branches. In order to determine whether or not the facet joint are causing pain, medial branch nerves could be diagnostically blocked and patient can determine whether or not there was a changes in their pain after the procedure. Medial branch block (MBB) is performed twice to confirm the correct diagnoses and the correct number of facets contributing to pain. Clinicians are looking for improvement of pain between 50 - 100% after each diagnostic block. When patient experiences significant reduced pain with diagnostic medical branch injections on 2 separate occasions, he/ she is considered a good candidate to proceed to radiofrequency ablation treatment. Radiofrequency ablation treatment: This procedure is performed after diagnostic medial branch injection is performed and it is determined (with a reasonable degree of certainty) that facet joints are the source of individuals back pain.
    [Show full text]
  • Endoscopic Rhizotomy for Chronic Lumbar Zygapophysial Joint Pain
    Xue et al. Journal of Orthopaedic Surgery and Research (2020) 15:4 https://doi.org/10.1186/s13018-019-1533-y RESEARCH ARTICLE Open Access Endoscopic rhizotomy for chronic lumbar zygapophysial joint pain Yuntao Xue1, Tao Ding1* , Dajie Wang2, Jianli Zhao3, Huilin Yang4, Xiaofeng Gu1, Dehong Feng1, Yafeng Zhang5, Hao Liu6, Fenglin Tang1, Wanyi Wang1, Miao Lu1 and Chao Wu7 Abstract Background: Chronic lumbar zygapophysial joint pain is a common cause of chronic low back pain. Percutaneous radiofrequency ablation (RFA) is one of the effective management options; however, the results from the traditional RFA need to be improved in certain cases. The aim of this study is to investigate the effect of percutaneous radiofrequency ablation under endoscopic guidance (ERFA) for chronic low back pain secondary to facet joint arthritis. Methods: This is a prospective study enrolled 60 patients. The cases were randomized into two groups: 30 patients in the control group underwent traditional percutaneous radiofrequency ablation, others underwent ERFA. The lumbar visual analog scale (VAS), MacNab score, and postoperative complications were used to evaluate the outcomes. All outcome assessments were performed at postoperative 1 day, 1 month, 3 months, 6 months, and 12 months. Results: There was no difference between the two groups in preoperative VAS (P > 0.05). VAS scores, except the postoperative first day, in all other postoperative time points were significantly lower than preoperative values each in both groups (P < 0.05). There was no significant difference between the two groups in VAS at 1 day, 1 month, and 3 months after surgery (P > 0.05). However, the EFRA demonstrated significant benefits at the time points of 3 months and 6 months (P > 0.05).
    [Show full text]
  • Diffusion Tensor Imaging for Assessment of Microstructural
    Chen et al. BMC Neurology (2019) 19:62 https://doi.org/10.1186/s12883-019-1295-5 RESEARCH ARTICLE Open Access Diffusion tensor imaging for assessment of microstructural changes associate with treatment outcome at one-year after radiofrequency Rhizotomy in trigeminal neuralgia Shu-Tian Chen1, Jen-Tsung Yang2, Hsu-Huei Weng1, Hsueh-Lin Wang1, Mei-Yu Yeh3 and Yuan-Hsiung Tsai1* Abstract Background: Trigeminal neuralgia (TN) is characterized by facial pain that may be sudden, intense, and recurrent. Neurosurgical interventions, such as radiofrequency rhizotomy, can relieve TN pain, but their mechanisms and effects are unknown. The aim of the present study was to investigate the microstructural tissue changes of the trigeminal nerve (TGN) in patients with TN after they underwent radiofrequency rhizotomy. Methods: Thirty-seven patients with TN were recruited, and diffusion tensor imaging was obtained before and two weeks after radiofrequency rhizotomy. By manually selecting the cisternal segment of the TGN, we measured the volume of the TGN, fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial diffusivity (AD), and radial diffusivity (RD). The TGN volume and mean value of the DTI metrics of the post-rhizotomy lesion side were compared with those of the normal side and those of the pre-rhizotomy lesion side, and they were correlated to the post-rhizotomy visual analogue scale (VAS) pain scores after a one-year follow-up. Results: The alterations before and after rhizotomy showed a significantly increased TGN volume and FA, and a decreased ADC, AD, and RD. The post-rhizotomy lesion side showed a significantly decreased TGN volume, FA, and AD compared with the normal side; however, no significant difference in the ADC and RD were found between the groups.
    [Show full text]
  • LETTERS to the EDITOR. Middle Cerebral Artery Tortuosity Associated
    J Neurosurg 130:1763–1788, 2019 Neurosurgical Forum LETTERS TO THE EDITOR Middle cerebral artery tortuosity tective factors against aneurysm formation.” Nevertheless, according to that explanation, it can be inferred that the associated with aneurysm incidence of aneurysms in patients with local tortuosity development should be decreased rather than increased. Therefore, it would be better for the authors to provide an in-depth ex- planation about the above results and arguments. TO THE EDITOR: We read with great interest the ar- Second, the authors stated, “There are a few rare ge- ticle by Kliś et al.2 (Kliś KM, Krzyżewski RM, Kwinta netic syndromes that are linked to the presence of vessel BM, et al: Computer-aided analysis of middle cerebral tortuosity, such as artery tortuosity syndrome or Loeys- artery tortuosity: association with aneurysm develop- Dietz syndrome.” The genetic syndromes they mention ment. J Neurosurg [epub ahead of print May 18, 2018; are systemic lesions involving multiple parts of vessels DOI: 10.3171/2017.12.JNS172114]). The authors conclude of the body and therefore often involve multiple intracra- that “an increased deviation of the middle cerebral artery nial aneurysms.1,3,5 However, this article did not provide (MCA) from a straight axis (described by relative length detailed information on the characteristics of intracranial [RL]), a decreased sum of all MCA angles (described by aneurysms, for example, the incidence of multiple aneu- sum of angle metrics [SOAM]), a local increase of the rysms, the specific sites of the MCA aneurysms (M1, M2, MCA angle heterogeneity, and an increase in changes in M3, M4), and the size of the aneurysms, etc.
    [Show full text]
  • UCSF Neurological Surgery
    UCSF Neurological Surgery 2018 Annual Report Contents 3 Brain Tumor Center 12 Pituitary Disorders 14 Brain and Spinal Injury Center 19 Pain and Peripheral Nerve Disorders 21 Neurospinal Disorders 25 Pediatric Neurosurgery 28 Movement Disorders 31 Vascular Neurosurgery Dear Colleague: 33 Epilepsy This year UCSF was ranked among the top three neurosurgery and neurology programs in the nation by 34 Center for Neural Engineering U.S. News & World Report’s 2018-19 survey of Best and Prostheses Hospitals. UCSF Medical Center was also ranked the best hospital in California and sixth nationwide. Our 35 Department also continues to receive the highest amount Community Extension of NIH funding of any academic neurosurgery program in the nation and our neurosurgery residency program is ranked #1 by Doximity for program reputation. © The Regents of the University of California We also continue to expand our services throughout the Bay Area, with UCSF adult neurosurgery available in Executive Editor: Ilona Garner Marin, Napa and Oakland to provide easy coordination Writer: Andrew Schwartz with local physicians and convenient access for patients Steve Babuljak, Elizabeth Fall, in those areas. We have also recently partnered with Photography: Melissa Lau, Susan Merrell, Barbara Ries, John Muir Health to offer neurosurgery evaluations at the Marco Sanchez, Tom Seawell new Berkeley Outpatient Center, a center for primary and specialty care serving patients in the East Bay. Illustration: Kenneth Xavier Probst I hope you enjoy reading about the clinical and research Design: Victoria Maier Magbilang, highlights from our Department in 2018. I am very proud Aqua Design Studio of the achievements we have made this year in advancing the field of neurosurgery and, as always, would like to thank you for allowing us to partner with you in the care of your patients.
    [Show full text]
  • Neuroimaging Modalities Currently Used
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.52.11.1318 on 1 November 1989. Downloaded from 1318 Book reviews In conclusion: this small book gives a the usefulness of many other types of sur- subject and is written by the best qualified neurosurgical approach to orbital diseases gery. They add "We do agree with Fields' authors. It is difficult to read because it must and tends to be mainly concerned with thought that the neurosurgical management have been difficult to write because the surgical aspects oforbital disease rather than of severe chronic pain remains in general in authors had to doubt politely the en- the wide variety of medical and paediatric an experimental phase in which respect we thusiasms of their friends and colleagues conditions that might affect it. say it resembles closely the non-neurosurg- who insisted that they had the answers where MD SANDERS ical management of such pain". That is bad none exist. news all round because it means that they are PATRICK D WALL not in a position to give us a straight answer Neurosurgical Treatment of Persistent Pain about the effect of surgery on pain. Introduction to Neuroimaging. By WILLIAM W Vol. II Pain and Headache. By JAN M GYBELS, How long does an experimental phase ORRISON, JR. (Pp 384; Illustrations: 489 MD, PhD and WILLIAM H SWEET MD, DSc, last? Let us take facet rhizotomy as an Radiog. Price: £43.50.) Edinburgh: Churchill DHC, FRCS Ed(Hon) Series Editor: Ph L example. This operation has been carried out Livingston, 1989. Gildenberg (Pp 442; Fig: 70; Price: since 1960 on tens of thousands ofback pain US$129.50; £88-20.) S Karger AG, Basel.
    [Show full text]
  • Selective Dorsal Rhizotomy (Sdr) St
    SELECTIVE DORSAL RHIZOTOMY (SDR) ST. LOUIS CHILDREN’S HOSPITAL • 280 beds, expanding to 473 in 2017 • 3,000 employees • 800 medical staff members • 1,300 auxiliary members and volunteers • More than 30 pediatric subspecialty departments and divisions • Level I Pediatric Trauma Center, the highest level of emergency care available • Serving patients from 50 states and 70 countries • Recognized as one of the Founded in 1879, St. Louis best children’s hospitals in Children’s Hospital is one of the nation by U.S. News the premier children’s hospitals & World Report in the nation. It serves not just the children of St. Louis, but • Has received the nation’s children across the world. The highest honor for nursing hospital provides a full range of excellence, the Magnet pediatric services to the St. Louis designation, from metropolitan area and a primary the American Nurses service region covering six states. Credentialing Center. As the pediatric teaching hospital for Washington University School of Medicine, St. Louis Children’s Hospital offers nationally recognized programs for physician training and research. | 1 | Table of Contents A Life-Changing Procedure ........................................................ 3 Hope for the Future .................................................................... 3 Understanding Muscle Stiffness .................................................. 6 Benefits of Dorsal Rhizotomy ...................................................... 7 Could Your Child Benefit? .........................................................
    [Show full text]
  • Procedure by Approach/Function Reference As Of: 2021-04-06 Proc Cat: NEU Show Notes: Yes
    Procedure by Approach/Function Reference as of: 2021-04-06 Proc Cat: NEU Show Notes: Yes NEURO ACH NEURO CRANIAL MRT ACH Only Endoscopic CRFCRCNEN Cranial Vault Reconstruction Endoscopic CROPITTREM Cranial Pit Tumour Exc Transnasal Endo MRT CRVTRSYN Cranial Vault Remodeling Synostosis CROPITRENM Cranial Pit Tumour Exc Transnasal Endo w Nav MRT CRVTRFOA Cranial Vault Remodelling w Fronto Orbital Advance CROPITHMRI Cranial Pit Tumour Transsphenoid Hypophysect MRT CROCOCENPM Craniotomy Corpus Callosotomy Epilepsy Nav Ped MRT CRSKBTUENM Cranial Skull Base Tumour Excision Endoscopic MRT Epilepsy NEURO CRANIAL EPILEPSY CRSROSAMRT Cranial Stereotax Robot ROSA Depth Elec Epi MRT Epilepsy CROEDEGIM Craniotomy Depth Elec/Grid Impl Epilepsy MRT CRBHIMELC Cranial Burr Hole Depth Elect Implant Epilepsy CROEDEGINM Craniotomy Depth Elec/Grid Impl Epilepsy w Nav MRT CREVROBR Cranial EVD/ROSA Bolt Removal CROEPLEM Craniotomy Lobectom+/-Elec+/-Grid Rem Epilepsy MRT CRSEEGLITT Cranial SEEG w Laser Thermal Therapy LITT CROEPLEAMR Craniotomy Lobectomy for Epilepsy Awake MRT CRSROSA Cranial Stereotax Robot ROSA Depth Elec Epi CROEPLEANM Craniotomy Lobectomy for Epilepsy Awake w Nav MRT CROCOCA Craniotomy Corpus Callosotomy Epilepsy w Nav CROEPEEGM Craniotomy Lobectomy for Epilepsy w ECOG MRT CROEDEGI Craniotomy Depth Elec/Grid Impl Epilepsy CROEPEEGNM Craniotomy Lobectomy for Epilepsy w ECOG Nav MRT CROEDEGIN Craniotomy Depth Elec/Grid Impl Epilepsy w Nav CROEPLENM Craniotomy Lobectomy for Epilepsy w Nav MRT CROEDEGR Craniotomy Depth Elec/Grid Removal Epilepsy
    [Show full text]